Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -852,824 | -594,364 | -389,850 | -200,291 | -858,281 |
| Depreciation Amortization | 89,694 | 68,243 | 45,023 | 22,862 | 74,435 |
| Accounts receivable | -101,799 | -42,350 | -46,020 | -10,709 | -56,236 |
| Accounts payable and accrued liabilities | 88,240 | 48,738 | 2,374 | -66,573 | 143,732 |
| Other Working Capital | -162,823 | -147,712 | -147,247 | -125,866 | -12,701 |
| Other Operating Activity | 297,819 | 175,893 | 178,204 | 144,917 | 94,090 |
| Operating Cash Flow | $-641,693 | $-491,552 | $-357,516 | $-235,660 | $-614,961 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -192,564 | 198,954 | 261,163 | 92,728 | -333,957 |
| PPE Investments | -76,372 | -54,486 | -28,424 | -17,178 | -70,361 |
| Purchase Of Investment | -166 | -165 | N/A | 0 | -25,900 |
| Other Investing Activity | -4,198 | -4,198 | -4,363 | -4,198 | -5,300 |
| Investing Cash Flow | $-273,300 | $140,105 | $228,376 | $71,352 | $-435,518 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 500,000 | 250,000 | 250,000 | N/A | 200,000 |
| Debt Repayment | 500,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 246,268 | 201,227 | 128,838 | 46,977 | 299,982 |
| Other Financing Activity | 850 | 503,600 | 2,150 | 4,200 | 494,997 |
| Financing Cash Flow | $1,247,118 | $954,827 | $380,988 | $51,177 | $994,979 |
| Exchange Rate Effect | -9,018 | -5,968 | -2,829 | -3,910 | 4,918 |
| Beginning Cash Position | 499,046 | 499,046 | 499,046 | 499,046 | 549,628 |
| End Cash Position | 822,153 | 1,096,458 | 748,065 | 382,005 | 499,046 |
| Net Cash Flow | $323,107 | $597,412 | $249,019 | $-117,041 | $-50,582 |
| Free Cash Flow | |||||
| Operating Cash Flow | -641,693 | -491,552 | -357,516 | -235,660 | -614,961 |
| Capital Expenditure | -76,372 | -54,486 | -28,424 | -17,178 | -70,361 |
| Free Cash Flow | -718,065 | -546,038 | -385,940 | -252,838 | -685,322 |